SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2427Apparently no ruling from the bench, as the hearing should be over by now. Not tuck-8/17/2010
2426Correction, those were the ten most important ones. It turns out that the TRO htuck-8/17/2010
2425All the legal documents pertaining to the upcoming motion hearing are linked to tuck18/17/2010
2424MNTA ‘ReadMeFirst’ updated: <i>2010-2011 news flow; index to legal/regulaDewDiligence_on_SI-8/16/2010
2423And also thanks to the IHub legal eagles, Sanofi's response to the FDA and Stuck-8/14/2010
2422[OT] The sugar-beet suit is old hat (see siliconinvestor.com ) and, as other posDewDiligence_on_SI-8/14/2010
2421In the stories I've read the USDA and not the FDA is identified as the respotom pope-8/14/2010
2420Objection, relevance! Is doing an environmental impact study in this case analotuck-8/14/2010
2419Judge overrules FDA. Judge's ruling uproots use of biotechnology beets Judgrkrw-8/14/2010
2418... buyers insisted on "best pricing terms" that automatically forced Ian@SI-8/11/2010
2417>>I fear that the measly 14% discount will allow Sanofi to implement long IRWIN JAMES FRANKEL-8/11/2010
2416It's been a single month admittedly, but one in which a lot has happened to tom pope-8/11/2010
2415Jim, I sincerely hope you're right. I still hold a full position. :( I fIan@SI-8/11/2010
2414We have not had a single month pass. Let's see where this is after we have IRWIN JAMES FRANKEL-8/11/2010
2413<i>It also leads to an increasing inference that TEVA won't make the gtom pope-8/11/2010
2412>>When cash flow starts coming in and if enough time goes by perhaps invesIRWIN JAMES FRANKEL-8/11/2010
2411I think for now, the perceived threat of Teva being approved is what will keep mrkrw18/11/2010
2410<i>>I reiterate my conclusion that the SNY suit has a snowball's chDewDiligence_on_SI-8/11/2010
2409So I've read all the briefs. I reiterate my conclusion that the SNY suit hatuck-8/11/2010
2408Air fizzing slowly out of a tire is volatile? :-)tom pope-8/10/2010
2407more volatile trading on this one. was tempted to buy a trading chunk here at tmopgcw-8/10/2010
2406Dew and others have dug out the defendant & intervenor briefs for the upcomituck18/10/2010
2405MNTA ‘ReadMeFirst’ updated: siliconinvestor.com <i>Reorganized to increaDewDiligence_on_SI-8/9/2010
2404Thank you. Looking forward to your post re Copaxone. Your opinion much respectedfred hayes-8/6/2010
2403<for approving a second version that is not fully characterized> This inBiotech Jim-8/6/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News